| NUVL |
Nuvalent, Inc. |
Porter James Richard |
|
2026-01-05 |
S - D |
4,727 |
96.85 |
457,809.95 |
297,656 |
| NUVL |
Nuvalent, Inc. |
Porter James Richard |
|
2026-01-05 |
S - D |
8,147 |
97.96 |
798,080.12 |
289,509 |
| NUVL |
Nuvalent, Inc. |
Porter James Richard |
|
2026-01-05 |
S - D |
1,337 |
98.52 |
131,721.24 |
288,172 |
| ACNT |
ASCENT INDUSTRIES CO. |
Portnoy Kimberly |
Officer
|
2026-01-05 |
F - D |
19 |
16.16 |
307.04 |
3,160 |
| ANTX |
AN2 Therapeutics, Inc. |
Prior Stephen David |
|
2026-01-05 |
S - D |
3,604 |
1.00 |
3,614.81 |
61,944 |
| PRTH |
Priority Technology Holdings, Inc. |
Kumar Rajiv |
Officer
|
2026-01-05 |
M - A |
12,500 |
0.00 |
0.00 |
46,812 |
| PRTH |
Priority Technology Holdings, Inc. |
Kumar Rajiv |
Officer
|
2026-01-05 |
M - A |
8,333 |
0.00 |
0.00 |
55,145 |
| PRTH |
Priority Technology Holdings, Inc. |
Kumar Rajiv |
Officer
|
2026-01-05 |
M - A |
12,500 |
0.00 |
0.00 |
67,645 |
|
Priority Technology Holdings, Inc. |
Kumar Rajiv |
Officer
|
2026-01-05 |
M - D |
12,500 |
0.00 |
0.00 |
0 |
|
Priority Technology Holdings, Inc. |
Kumar Rajiv |
Officer
|
2026-01-05 |
M - D |
8,333 |
0.00 |
0.00 |
0 |
|
Priority Technology Holdings, Inc. |
Kumar Rajiv |
Officer
|
2026-01-05 |
M - D |
12,500 |
0.00 |
0.00 |
25,000 |
| FG |
F&G Annuities & Life, Inc. |
QUIRK RAYMOND R |
Director
|
2026-01-05 |
A - A |
941 |
0.00 |
0.00 |
11,812 |
| QS |
QuantumScape Corp |
Straubel Jeffrey B |
|
2026-01-05 |
S - D |
27,106 |
11.28 |
305,690.63 |
239,722 |
| QS |
QuantumScape Corp |
Holme Timothy |
|
2026-01-05 |
C - A |
166,440 |
0.00 |
0.00 |
1,417,823 |
| QS |
QuantumScape Corp |
Holme Timothy |
|
2026-01-05 |
S - D |
166,440 |
11.28 |
1,877,110.32 |
1,251,383 |
| QS |
QuantumScape Corp |
Holme Timothy |
|
2026-01-05 |
C - A |
44,922 |
0.00 |
0.00 |
44,922 |
| QS |
QuantumScape Corp |
Holme Timothy |
|
2026-01-05 |
S - D |
44,922 |
11.28 |
506,634.81 |
0 |
|
QuantumScape Corp |
Holme Timothy |
|
2026-01-05 |
C - D |
166,440 |
0.00 |
0.00 |
7,861,138 |
|
QuantumScape Corp |
Holme Timothy |
|
2026-01-05 |
C - D |
44,922 |
0.00 |
0.00 |
1,483,941 |
| CLYM |
Climb Bio, Inc. |
Shah Rajeev M. |
Director
10% Owner
|
2026-01-05 |
P - A |
7,111 |
3.50 |
24,888.50 |
3,403,429 |
| CLYM |
Climb Bio, Inc. |
Shah Rajeev M. |
Director
10% Owner
|
2026-01-05 |
P - A |
7,111 |
3.50 |
24,888.50 |
3,403,429 |
| CLYM |
Climb Bio, Inc. |
Shah Rajeev M. |
Director
10% Owner
|
2026-01-05 |
P - A |
7,111 |
3.50 |
24,888.50 |
3,403,429 |
| CLYM |
Climb Bio, Inc. |
Shah Rajeev M. |
Director
10% Owner
|
2026-01-05 |
P - A |
7,111 |
3.50 |
24,888.50 |
3,403,429 |
| CLYM |
Climb Bio, Inc. |
Shah Rajeev M. |
Director
10% Owner
|
2026-01-05 |
P - A |
7,111 |
3.50 |
24,888.50 |
3,403,429 |
| RXRX |
RECURSION PHARMACEUTICALS, INC. |
Gibson Christopher |
Director
|
2026-01-05 |
C - A |
60,000 |
0.00 |
0.00 |
973,839 |